Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, δ-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1
Peter Stålberg(Uppsala University Hospital), Britt Skogseid(Uppsala University), Jonas Rastad(Modus Therapeutics (Sweden)), Per Grimfjärd(Uppsala University Hospital), Daniel M. Lindberg(Kempe Foundation), Mårten Santesson(Uppsala University Hospital), Yinghua Zhou(Uppsala University Hospital), Kjell Öberg(Uppsala University Hospital), Gunnar Westin(Uppsala University Hospital), Anders Gobl(Uppsala University Hospital), Shu Wang(Georgetown Lombardi Comprehensive Cancer Center)
Cited by 55
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k